Ford suspends guidance, details $1.5B tariff impact, highlighting its strong balance sheet and cost-saving actions to mitigate tariff exposure.
Trump signs executive actions to boost domestic drug manufacturing and tighten oversight on gain-of-function research, raising concerns over potential higher costs and shortages.
Trump DOJ moves to dismiss lawsuit challenging FDA's mifepristone regulations, citing procedural issues and lack of standing.
Ford suspends guidance, details $1.5B tariff impact, highlighting its strong balance sheet and cost-saving actions to mitigate tariff exposure.
Trump signs executive actions to boost domestic drug manufacturing and tighten oversight on gain-of-function research, raising concerns over potential higher costs and shortages.
Trump DOJ moves to dismiss lawsuit challenging FDA's mifepristone regulations, citing procedural issues and lack of standing.